When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALXN - European advisory group backs expanded label for Alexion's Ultomiris
Alexion Pharmaceuticals Inc.
The European Medicines Agency's advisory group CHMP has adopted a positive opinion backing the use of Alexion Pharmaceuticals' (NASDAQ:ALXN) Ultomiris (ravulizumab) for patients with a body weight of at least 10 kg with atypical haemolytic uremic syndrome (aHUS) who are complement inhibitor treatment-naïve or have received eculizumab (Soliris) for at least three months and have evidence of response to eculizumab.
More news on: Alexion Pharmaceuticals, Inc., Healthcare stocks news,